PatientIQ Secures $30 Million Series C Funding for Patient Outcomes Enhancement

PatientIQ Raises $30 Million in Series C Funding

In a significant move to enhance patient-reported outcomes intelligence, PatientIQ has successfully secured $30 million in Series C funding. This round was spearheaded by Hughes Company, a Chicago-based growth equity firm specializing in healthcare software and technology, marking a pivotal point in PatientIQ's growth journey.

Founded to revolutionize how patient outcomes are measured and utilized, PatientIQ is currently trusted by over 870 healthcare organizations, encompassing a diverse range of medical specialties. The platform has made a substantial impact, analyzed and improved outcomes for an impressive 17 million patients across the United States. The funding will enable PatientIQ to deepen its integration within healthcare systems, expand its proprietary benchmarks, and reach further into additional medical specialties and industry sectors, including medical devices and life sciences.

Travis Hughes, the Founder and Managing Partner of Hughes Company, highlighted the rigorous study the firm undertook over the past year regarding the patient-reported outcomes landscape. He expressed excitement at being part of a company that is reshaping healthcare metrics by creating a new category vital for enhancing care quality. Hughes Company joins other prominent investors such as Health Enterprise Partners and August Capital in backing PatientIQ.

Since its last funding round in 2022, PatientIQ has seen remarkable growth; its electronic health record (EHR) integrated network expanded from 200 to over 870 healthcare organizations. More than 70 million patient outcomes have been recorded on the platform, showcasing PatientIQ's capacity for automating data collection across various medical disciplines. The company collaborates with leading medical device and life science companies and manages national clinical registries for prominent organizations like the American Academy of Orthopaedic Surgeons (AAOS) and the Society for Thoracic Surgeons.

Matthew Gitelis, CEO of PatientIQ, emphasized the challenges within the healthcare sector related to actionable outcomes data, attributing them to infrastructural limitations rather than a lack of intent. He conveyed confidence that PatientIQ’s decade-long commitment to building robust systems across specialties and workflows is beginning to pay off. This fresh investment serves not only as a validation of their innovative approach but also as a means to propel their mission further into the healthcare landscape.

The timing of this investment is crucial, especially with the Centers for Medicare & Medicaid Services (CMS) actively expanding patient-reported outcome requirements and various payers beginning to align reimbursement with demonstrated clinical outcomes. Companies within the medical device and life science sectors are facing increasing pressure to provide real-world evidence—data that is imperative for regulatory compliance and effective product differentiation. PatientIQ stands at the forefront of this shift, poised to become the standard in outcomes intelligence by providing the necessary data insights that health systems, researchers, and industry stakeholders require to assess effectiveness and enhance patient care.

Hughes Company focuses exclusively on healthcare sector investments, aiming to elevate companies that demonstrate potential for significant growth and innovation in patient outcomes and operational efficiency. They recognize PatientIQ’s role in shaping the future of healthcare, utilizing data to bridge gaps between patients and healthcare providers.

As PatientIQ continues to evolve, this latest round of funding represents a collective commitment to improving patient care by tapping into the transformative power of data and outcomes intelligence. With increased resources and strategic partnerships, PatientIQ is set to further innovate and expand its marketplace, ultimately connecting patients to essential products and services while fostering better health outcomes.